A nurse is preparing to administer ticarcillin/clavulanate 3.1 g by intermittent IV bolus over 30 min. Available is ticarcillin/clavulanate 3.1 g in 50 ml 0.9% sodium chloride (NSS). The nurse should set the IV pump to deliver how many mL/hr? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.) _mL/hr

A) "Reduce intake of potassium-rich foods":
Hydrochlorothiazide is a diuretic medication that can cause potassium loss through increased urinary excretion. Therefore, instructing the client to reduce intake of potassium-rich foods could further decrease potassium levels, leading to hypokalemia. Instead, clients taking hydrochlorothiazide should be encouraged to consume potassium-rich foods to help maintain normal potassium levels, unless otherwise instructed by their healthcare provider.

B) "Take this medication before bedtime":
While hydrochlorothiazide can be taken once daily, it is typically recommended to take it in the morning rather than before bedtime. Taking the medication earlier in the day can help minimize the need to wake up during the night to urinate, as it is a diuretic that increases urine production. Therefore, instructing the client to take hydrochlorothiazide before bedtime is not the optimal recommendation.

C) "Avoid grape juice":
There is no significant interaction between hydrochlorothiazide and grape juice. In general, grapefruit juice is known to interact with certain medications by inhibiting cytochrome P450 enzymes in the liver, affecting drug metabolism. However, grape juice is not known to interact with hydrochlorothiazide, so advising the client to avoid grape juice is not necessary.

D) "Monitor for leg cramps":
This is the correct instruction. Leg cramps can be a potential side effect of hydrochlorothiazide therapy due to electrolyte imbalances, particularly hypokalemia. By monitoring for leg cramps, the client can promptly report any symptoms to their healthcare provider for further evaluation and management. This instruction promotes client safety and awareness of potential adverse effects associated with the medication."

B) Tachycardia:
Anticholinergic drugs, by blocking the action of acetylcholine at muscarinic receptors, can lead to increased sympathetic activity, resulting in tachycardia. Acetylcholine normally acts to moderate heart rate via vagal stimulation, so blocking its effects with anticholinergic medications can lead to an unopposed sympathetic response, causing an increase in heart rate.

A) Urinary Frequency:
Anticholinergic drugs typically cause urinary retention rather than urinary frequency. By blocking muscarinic receptors in the bladder, these medications can lead to decreased bladder contractility and urinary retention. Urinary frequency is not a common adverse effect of anticholinergic drugs.

C) Tachypnea:
Tachypnea, or rapid breathing, is not a typical adverse effect of anticholinergic medications. While anticholinergic drugs can affect respiratory secretions and cause drying of mucous membranes, leading to potential respiratory issues, tachypnea specifically is not commonly associated with their use.

D) Hypotension:
Anticholinergic drugs are more likely to cause hypertension rather than hypotension. By blocking the parasympathetic nervous system, these medications can lead to sympathetic dominance, resulting in increased blood pressure. Hypotension is not a typical adverse effect of anticholinergic drugs.